2003
DOI: 10.1016/s0026-0495(03)00148-3
|View full text |Cite
|
Sign up to set email alerts
|

Alanine administration does not stimulate gluconeogenesis in preterm infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 30 publications
0
10
0
Order By: Relevance
“…To the best of our knowledge, there are no data about alanine supplementation in heart failure. Moreover, the few studies assessing the effects of alanine supplementation failed to indicate any beneficial effects in preterm infants or in the severely ill (29,49).…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, there are no data about alanine supplementation in heart failure. Moreover, the few studies assessing the effects of alanine supplementation failed to indicate any beneficial effects in preterm infants or in the severely ill (29,49).…”
Section: Discussionmentioning
confidence: 99%
“…Studies measuring gluconeogenesis in nonfasted premature infants show that the availability of gluconeogenic substrates is not impaired [81].…”
Section: Gluconeogenesismentioning
confidence: 99%
“…In infants born as early as 25–26 weeks of gestation parenteral glycerol enhances gluconeogenesis [13]. On the other hand, administration of alanine did not enhance gluconeogenesis, despite a high plasma alanine level [14]. Glycerol enters the gluconeogenic pathway at the level of the triose phosphate pool whereas alanine enters at the pyruvate level (fig.…”
Section: Altered Glucose Metabolism In Preterm Infantsmentioning
confidence: 99%